Dividend Policy - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 105,554,000 shares[13] - The proposed cash dividend for 2019 is CNY 1.5 per 10 shares, totaling CNY 15,833,100.00, with no stock dividends or capital reserve transfers proposed[119] - The cash dividend payout ratio for 2019 was 28.37% of the net profit attributable to shareholders[121] - The cash dividend for 2018 was also CNY 1.5 per 10 shares, with a similar payout ratio of 28.78%[120] - The cash dividend for 2017 was CNY 1.3 per 10 shares, with a payout ratio of 29.62%[120] - The company has maintained a consistent cash dividend distribution strategy over the past three years, with no stock dividends issued[120] Financial Performance - The company's operating revenue for 2019 was CNY 493,948,395.76, representing a 4.56% increase compared to CNY 472,405,817.98 in 2018[25] - The net profit attributable to shareholders for 2019 was CNY 55,814,395.22, a 1.47% increase from CNY 55,008,181.43 in 2018[25] - The net profit after deducting non-recurring gains and losses was CNY 47,913,876.35, up 5.68% from CNY 45,340,348.62 in 2018[25] - The net cash flow from operating activities decreased by 40.84% to CNY 59,707,863.02 from CNY 100,929,510.11 in 2018[25] - The total assets at the end of 2019 were CNY 1,290,421,022.87, a 38.27% increase from CNY 933,283,956.27 at the end of 2018[25] - The net assets attributable to shareholders increased by 9.96% to CNY 685,929,389.18 from CNY 623,786,053.96 at the end of 2018[25] - The basic earnings per share for 2019 was CNY 0.5408, a slight increase of 0.90% from CNY 0.5360 in 2018[25] - The diluted earnings per share for 2019 was CNY 0.5405, up 0.88% from CNY 0.5358 in 2018[25] - The weighted average return on equity for 2019 was 8.60%, down from 9.15% in 2018[25] Technology and Innovation - The company has developed multiple core technologies in membrane separation, with many at a leading domestic or advanced international level, and has implemented measures to protect these technologies[12] - The company emphasizes the importance of R&D investment to maintain its competitive edge and adapt to market changes[6] - The company has established a complete R&D system for ceramic membranes and membrane separation technology, focusing on key technology research and solution design[40] - The company has accumulated 67 invention patents, 96 utility model patents, and 5 design patents, with 108 patent applications accepted as of December 31, 2019[50] - The company has developed a waste salt resource utilization technology, demonstrating its commitment to zero discharge and deep treatment of industrial wastewater[43] - The company is focusing on the development of lithium adsorption materials and aims to prepare for large-scale production[110] - The company will continue to invest in R&D for membrane materials and technologies to meet the growing demands of downstream applications[108] Market and Sales Strategy - The company aims to enhance project signing and mitigate industry volatility risks by expanding the application fields of its solutions and improving client economic benefits[9] - The company’s revenue model is based on providing comprehensive membrane integration technology solutions, which includes design, production, and operational support[36] - The company’s sales strategy involves customized solutions based on client needs, with a focus on integrated technology solutions as the core of its marketing efforts[39] - The company actively expanded its market presence in new fields such as black and odorous water treatment and industrial wastewater "zero discharge" during the reporting period[58] - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2021[124] Financial Management and Investments - The company raised a total of RMB 192,717,000 through the public offering of 16.1 million shares at RMB 11.97 per share, with a net amount of RMB 154,190,577.66 after deducting fees[99] - The company has established a guarantee amounting to 17.31 million CNY, with details pending[168] - The company engaged in entrusted financial management, with a total amount of ¥11,000 million, including ¥5,000 million from raised funds and ¥6,000 million from self-owned funds[174] - The company has a diversified investment strategy, including bank wealth management products with varying risk levels[174] - The company reported a total of 3,000 million in structured deposits for the year 2019, with a return rate of 3.75%[176] Corporate Governance and Compliance - The company has committed to fulfilling all promises made by actual controllers, shareholders, and related parties during the reporting period[122] - The company will ensure compliance with national laws and regulations to avoid engaging in competitive business activities[127] - The company has established measures to prevent competition with its controlled enterprises, ensuring no similar business activities are conducted[127] - The company will take appropriate actions to resolve any potential conflicts of interest that may arise from competitive business activities[127] - The company has implemented changes in accounting policies in accordance with new financial instrument standards effective from January 1, 2019, which do not affect profit or loss, total assets, or net assets[145] Social Responsibility and Sustainability - The company has actively participated in social responsibility initiatives, including donations to local schools for safe drinking water[183] - The company has established a science popularization education base for middle and primary school students[184] - The company emphasizes equal development opportunities for employees through various training and career development programs[183] - Jiangsu Jiuwu High-Tech Co., Ltd. is committed to sustainability, with plans to invest 100 million yuan in green technology initiatives over the next three years[124] Risk Management - The company has established a robust framework for managing financial risks associated with its investment activities[174] - The company’s financial risk has decreased, enhancing its ability to withstand risks[199] - The company has implemented an employee stock incentive plan, approved by the board on October 7, 2018, to enhance employee motivation and retention[151]

江苏久吾高科技股份有限公司 2020 年第一季度报告全文 证券代码：300631 江苏久吾高科技股份有限公司 2020年第一季度报告 2020年04月 1 江苏久吾高科技股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业总收入（元） | 68,309,501.83 | 81,394,648.43 | -16.08% | | 归属于上市公司股东的净利润（元） | ...

Financial Performance - Operating revenue for the reporting period was ¥130,955,748.48, a decrease of 18.07% year-on-year[7]. - Net profit attributable to shareholders was ¥19,679,209.20, down 6.78% compared to the same period last year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥18,774,938.35, a decrease of 3.78% year-on-year[7]. - Basic earnings per share for the reporting period was ¥0.1918, a decline of 6.76% compared to the same period last year[7]. - The weighted average return on equity was 3.07%, down 0.52% from the previous year[7]. - The total comprehensive income attributable to the parent company for Q3 2019 was CNY 19,679,209.20, down from CNY 21,109,545.05 in Q3 2018[38]. - The net profit for Q3 2019 was CNY 20,202,241.61, a decline of 5.8% from CNY 21,446,686.01 in Q3 2018[35]. - The net profit for Q3 2019 was CNY 19,070,182.25, down 8.32% from CNY 20,804,212.88 in Q3 2018[40]. - The total profit for Q3 2019 was CNY 21,857,633.24, down 7.94% from CNY 23,750,125.02 in Q3 2018[38]. - The net profit for Q3 2019 was CNY 27,221,258.61, a decrease of 9.0% from CNY 29,904,142.06 in Q3 2018[47]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,223,521,651.65, an increase of 31.10% compared to the end of the previous year[7]. - Total assets reached 1.22 billion yuan, an increase from 933.28 million yuan at the end of the previous year[25]. - Total assets reached CNY 1,208,137,390.27, an increase of 31.9% from CNY 915,991,126.92 at the end of 2018[32]. - Total liabilities increased to CNY 567,058,209.85, up 92.0% from CNY 295,366,630.08 at the end of 2018[32]. - The company's total liabilities amounted to CNY 295,366,630.08, with current liabilities at CNY 260,594,635.35[63]. - The total equity attributable to the parent company was CNY 623,786,053.96[62]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥14,940,170.16, a significant decrease of 88.19%[7]. - Net cash flow from operating activities decreased by 88.19% year-on-year, resulting in a net cash outflow due to reduced cash inflows and increased cash outflows from operating activities[15]. - Cash flow from operating activities generated a net amount of CNY 14,940,170.16, significantly lower than CNY 126,499,569.56 in the same period last year[51]. - The net cash flow from operating activities for the current period is CNY 20,931,151.61, a decrease of 81.9% compared to CNY 115,965,228.03 in the previous period[53]. - The total cash inflow from operating activities is CNY 306,369,884.57, down 17% from CNY 369,301,615.02 in the previous period[53]. Investments and Expenses - The company reported non-recurring gains and losses totaling ¥4,782,840.83 for the year-to-date[8]. - Management expenses rose by 47.02% year-on-year, primarily due to the recognition of share-based payment expenses[15]. - Financial expenses surged by 2560.5% year-on-year, mainly due to interest expenses on bank borrowings[15]. - Research and development expenses for Q3 2019 were CNY 6,979,498.94, an increase of 60.0% from CNY 4,361,297.94 in Q3 2018[34]. - Research and development expenses increased to CNY 6,460,441.86 in Q3 2019, up 56.83% from CNY 4,115,816.80 in the same period last year[38]. - Research and development expenses increased to CNY 13,815,823.23, representing a rise of 23.4% from CNY 11,203,694.68 in the same quarter last year[47]. Shareholder Information - The total number of shareholders at the end of the reporting period was 10,535[11]. - The largest shareholder, Shanghai Dehui Group, holds 30.32% of the shares, totaling 32,000,000 shares[11]. Other Financial Metrics - Cash and cash equivalents increased by 145.43% compared to the beginning of the period, mainly due to an increase in short-term borrowings[15]. - Cash and cash equivalents stood at CNY 126,004,480.65, indicating liquidity position[61]. - The ending balance of cash and cash equivalents is CNY 271,114,080.19, up from CNY 48,187,341.63 in the previous period, reflecting a substantial increase of 462%[55]. - The company reported a financial expense of CNY 1,496,023.79 in Q3 2019, significantly higher than CNY 2,299.73 in the previous year[38]. - The company experienced a credit impairment loss of CNY 3,658,875.26 in Q3 2019, indicating challenges in asset quality[38].

Financial Performance - Total operating revenue for the first half of 2019 was CNY 159,749,229.86, representing a 45.20% increase compared to CNY 110,016,507.27 in the same period last year[19]. - Net profit attributable to shareholders of the listed company was CNY 12,573,241.39, up 22.65% from CNY 10,251,594.93 year-on-year[19]. - Net profit after deducting non-recurring gains and losses increased by 60.59%, reaching CNY 8,694,671.41 compared to CNY 5,414,139.60 in the previous year[19]. - Basic earnings per share rose by 18.32% to CNY 0.1182 from CNY 0.0999 in the previous year[19]. - The company achieved a revenue of CNY 159.75 million in the first half of 2019, representing a year-on-year growth of 45.20%[45]. - The net profit attributable to shareholders was CNY 12.57 million, an increase of 22.65% compared to the previous year[45]. - The net profit after deducting non-recurring gains and losses was CNY 8.69 million, showing a significant growth of 60.59% year-on-year[45]. - The company reported a total profit of CNY 20.31 million for the first half of 2019, a 54.7% increase from CNY 13.13 million in the first half of 2018[162]. - The company's net profit margin for the first half of 2019 was impacted by increased operating costs, with operating profit margins needing to be monitored closely[160]. Cash Flow and Financial Position - The net cash flow from operating activities was negative at CNY -12,669,322.57, a decline of 126.04% from CNY 48,654,333.29 in the same period last year[19]. - The company’s cash and cash equivalents grew by 171.68% compared to the beginning of the period, primarily due to an increase in short-term borrowings[36]. - The company’s cash flow from financing activities increased significantly by 869.04%, amounting to ¥224,816,215.36, mainly due to an increase in loan amounts[52]. - The total cash and cash equivalents at the end of the first half of 2019 amounted to 313,746,712.86 yuan, compared to 83,184,010.49 yuan at the end of the first half of 2018, marking an increase of about 276%[171]. - The total liabilities increased to ¥549,434,311.13 from ¥304,150,530.02, representing an increase of approximately 80%[154]. - The company’s short-term borrowings surged to RMB 259,000,000.00 from RMB 33,000,000.00, representing an increase of approximately 684%[152]. Research and Development - Research and development expenses amounted to CNY 8.26 million, accounting for 5.17% of operating revenue, indicating a strong commitment to innovation[38]. - The company has developed various integrated processes for lithium salt resources and successfully created lithium adsorption materials, laying a solid foundation for future business growth[33]. - The company has accumulated 62 invention patents and 87 utility model patents, showcasing its strong R&D capabilities[38]. - The company has established a complete research and development system for ceramic membrane materials and membrane separation technology, ensuring continuous technological innovation[30]. - Research and development expenses for the first half of 2019 were CNY 1,200 million, accounting for 10% of total revenue, aimed at enhancing product innovation[179]. Market and Business Strategy - The main business focus is on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for industrial separation and environmental water treatment[26]. - The company’s revenue model is based on providing comprehensive membrane integration technology solutions, which includes the sale of membrane materials and complete equipment[28]. - The company has made progress in lithium extraction from salt lakes, titanium dioxide, industrial water treatment, and black odor water governance, expanding its technical reserves[32]. - The company benefits from government policies that support the development of membrane materials and technologies, enhancing market opportunities[31]. - The company has established a significant brand presence in the membrane materials industry, leveraging its product quality and technical service capabilities[41]. Risk Management and Compliance - The company has detailed the risks it faces and corresponding countermeasures in the report[4]. - The company emphasizes the need to optimize management structure and reduce costs to enhance competitiveness in a challenging market environment[92]. - The company has not faced any major litigation or arbitration matters during the reporting period[104]. - The company has not reported any significant changes in its expected operating performance for the upcoming period[91]. - The company is focusing on expanding its market presence through strategic financial products[76]. Shareholder and Equity Information - The company plans not to distribute cash dividends or issue bonus shares[5]. - The total number of ordinary shareholders at the end of the reporting period was 16,125[135]. - The largest shareholder, Shanghai Dehui Group, holds 30.32% of the shares, totaling 32,000,000 shares[135]. - The second-largest shareholder, Nanjing University Asset Management, holds 7.11% with 7,504,000 shares[135]. - The company has not reported any significant related party transactions during the reporting period[113]. Subsidiaries and Investments - The subsidiary Anhui Jiuwu Tianhong Environmental Technology Co., Ltd. achieved an operating income of 25,422,568.9 RMB and a net profit of 8,857,941.49 RMB, contributing positively to the overall performance[89]. - The company has a total loan amount of 500,000 RMB to Anhui Jiuwu Tianhong Environmental Technology Co., Ltd. at an interest rate of 4.64% for daily operations[85]. - The company has made a significant equity investment of CNY 58.8 million in a new joint venture with a 49% stake[63]. Governance and Compliance - The company has established a multi-level governance structure, including a board of directors, supervisory board, and various specialized committees[190]. - The company adheres to the enterprise accounting standards, ensuring that the financial statements reflect its financial status, operating results, and cash flows accurately[195]. - The company has not encountered any significant issues that would raise doubts about its ability to continue as a going concern for the next 12 months[193].

Financial Performance - The company's operating revenue for 2018 was CNY 472,405,817.98, representing a 60.93% increase compared to CNY 293,538,746.86 in 2017[20]. - The net profit attributable to shareholders for 2018 was CNY 55,008,181.43, which is a 22.14% increase from CNY 45,038,324.73 in 2017[20]. - The net cash flow from operating activities improved significantly to CNY 100,929,510.11, a 232.16% increase from a negative CNY 76,369,589.16 in 2017[20]. - The total assets at the end of 2018 reached CNY 933,283,956.27, marking a 23.73% increase from CNY 754,270,063.62 at the end of 2017[20]. - The basic earnings per share for 2018 was CNY 0.5360, up 14.46% from CNY 0.4683 in 2017[20]. - The company reported a quarterly revenue of CNY 202,547,819.26 in Q4 2018, contributing to a total annual revenue growth[22]. - The net profit attributable to shareholders in Q4 2018 was CNY 23,647,041.45, indicating strong performance in the last quarter[22]. - The company's net assets attributable to shareholders increased by 7.40% to CNY 623,786,053.96 at the end of 2018[20]. - Non-recurring gains and losses totaled CNY 9,667,832.81 in 2018, compared to CNY 7,496,484.67 in 2017, reflecting an increase in government subsidies and other income[26]. - The weighted average return on equity for 2018 was 9.15%, an increase from 8.59% in 2017[20]. Research and Development - The company is committed to enhancing its research and development investments to maintain its competitive edge in technology and brand[4]. - The company has developed multiple core technologies in membrane separation, with most being at a leading domestic or advanced international level[7]. - The company’s R&D efforts are focused on independent innovation, creating a continuous technological driving force for its products[33]. - The company invested CNY 17.63 million in R&D, accounting for 3.73% of its operating revenue, to enhance its technological capabilities and product development[43]. - The company has established a complete technical system for membrane material preparation and application, holding numerous patents and proprietary technologies[36]. Market Position and Strategy - The company maintains a leading position in the domestic ceramic membrane industry, facing increasing competition that has affected product gross margins[4]. - The company aims to expand its application of membrane integration technology solutions across various industries, including biomedicine, chemicals, and environmental water treatment[5]. - The company plans to mitigate risks associated with downstream industry fluctuations by diversifying its client base and improving the economic benefits of its technology solutions[5]. - The company is focused on optimizing its management structure and reducing costs to sustain its market position[4]. - The company has established a strong brand image in the industry, leveraging its product quality and technical service capabilities to gain market recognition[45]. Financial Management and Investments - The company raised a total of RMB 192.72 million by issuing 16.1 million shares at RMB 11.97 per share, with a net amount of RMB 154.19 million after deducting fees[86]. - The company has achieved 100% progress on the wastewater treatment and recycling membrane equipment project, with a total investment of RMB 4.95 million[87]. - The company has not encountered any major changes in the feasibility of the projects or any violations in the management of raised funds[88]. - The company has timely and accurately disclosed the status of raised funds, ensuring compliance with regulations[88]. - The company has implemented measures to ensure timely recovery of investments[147]. Corporate Governance and Compliance - The company is committed to improving corporate governance and risk management to protect investor interests[97]. - The company has fulfilled all commitments made by its controlling shareholders and related parties during the reporting period[105]. - The company has not reported any non-compliance with commitments made to minority shareholders[116]. - The company will adhere to the latest regulatory requirements regarding compensation measures as they arise[115]. - The company has not engaged in entrusted loans during the reporting period, indicating a focus on direct financial activities[152]. Shareholder Information and Dividends - The company reported a cash dividend of 1.5 RMB per 10 shares, with a total base of 105,554,000 shares[7]. - The proposed cash dividend is ¥1.50 per 10 shares (before tax), totaling ¥15,833,100.00, which represents 100% of the total profit distribution[102][104]. - The cash dividend for 2018 is 28.78% of the consolidated net profit attributable to the company's ordinary shareholders[104]. - The cash dividend amount for 2017 was ¥13,341,120.00, which was 29.62% of the consolidated net profit[104]. - The company has a cash dividend policy that aligns with its articles of association and shareholder resolutions[101]. Future Outlook - Future outlook indicates a projected revenue growth of 30% for 2019, driven by new product launches and market expansion strategies[107]. - The company plans to focus on ceramic membrane materials and membrane separation technology, aiming to become a leading enterprise in the global ceramic membrane industry within a few years[95]. - The company aims to enhance its market position in the pharmaceutical, food, and chemical industries while focusing on industrial wastewater treatment and resource utilization[96]. - The company plans to actively utilize capital market platforms to promote external development and achieve industrial chain extension[97]. - The company is committed to increasing its core competitiveness and sustainable profitability through technological advancements and market expansion[114].

江苏久吾高科技股份有限公司 2019 年第一季度报告全文 江苏久吾高科技股份有限公司 2019 年第一季度报告 2019 年 04 月 1 江苏久吾高科技股份有限公司 2019 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入（元） | 81,394,648.43 | 46,015,898.53 | 76.88% | | 归属于上市公司股东的净利润（元） | 5,375,843.61 | 3,081 ...

江苏久吾高科技股份有限公司 2018 年第三季度报告全文 江苏久吾高科技股份有限公司 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2018 年第三季度报告全文 第二节 公司基本情况 2018 年第三季度报告 2018 年 10 月 1 江苏久吾高科技股份有限公司 2018 年第三季度报告全文 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 948,306,974.58 | | 754,270,063.62 | 25.73% | | 归属于上市公司股东的净资产 | 598,002,812 ...

Financial Performance - Total operating revenue for the first half of 2018 was CNY 110,016,507.27, representing a 7.40% increase compared to CNY 102,432,293.00 in the same period last year[20]. - Net profit attributable to shareholders was CNY 10,251,594.93, up 23.66% from CNY 8,290,465.68 year-on-year[20]. - Basic earnings per share increased by 8.12% to CNY 0.0999, compared to CNY 0.0924 in the same period last year[20]. - The company reported a total profit of CNY 13,126,281.77, which is a 30.5% increase from CNY 10,069,856.95 in the same period last year[170]. - The total comprehensive income for the period was CNY 11,264,538.67, compared to CNY 8,688,532.52 in the previous year, marking a growth of 29.9%[171]. - The company achieved investment income of CNY 1,624,754.43, a substantial increase from CNY 26,425.43 in the previous year[170]. - Operating profit increased to CNY 11,317,946.86, representing a growth of 44.5% compared to CNY 7,860,468.16 in the previous year[170]. Cash Flow and Assets - Net cash flow from operating activities improved significantly to CNY 48,654,333.29, a 283.54% increase from a negative CNY 26,509,254.60 in the previous year[20]. - Cash generated from operating activities was CNY 203,509,504.84, significantly higher than CNY 84,049,636.31 in the previous period[176]. - Total cash inflow from investment activities reached ¥313,942,239.70, compared to ¥30,028,010.96 in the prior period, indicating a strong increase in investment recovery[178]. - The total amount of raised funds during the reporting period was CNY 21.8 million, with a cumulative investment of CNY 50.61 million[62]. - Cash and cash equivalents increased by 131.79% compared to the beginning of the period, attributed to an increase in net cash flow from operating activities[35]. - Total assets at the end of the reporting period reached CNY 866,931,378.36, a 14.94% increase from CNY 754,270,063.62 at the end of the previous year[20]. Research and Development - Research and development expenses for the first half of 2018 amounted to 7.09 million yuan, accounting for 6.44% of operating revenue, indicating a strong commitment to R&D investment[37]. - The company has established a complete R&D system for ceramic membrane materials and membrane separation technology, promoting continuous technological innovation[30]. - The company plans to enhance its research and development investments to maintain its competitive edge in the ceramic membrane industry, which is facing increased competition[87]. Market and Business Strategy - The main business focus is on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for process separation and special water treatment[27]. - The company continues to strengthen its market expansion efforts, particularly in lithium extraction and industrial wastewater treatment sectors[44]. - The company plans to invest in the expansion of the "ceramic membrane and complete equipment production line" and the "separation membrane equipment industrialization project for wastewater treatment and recycling" to enhance R&D and production capabilities[107]. - The company aims to maintain a market share of no less than the current level in the domestic ceramic membrane market over the next five years[108]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares[6]. - The actual controller and shareholders have fulfilled their commitments regarding share transfer restrictions, with a lock-up period of 36 months from the date of listing[94]. - The company has established a profit distribution policy and dividend return plan, which includes a commitment to vote in favor of profit distribution proposals that align with these policies[99]. - The company will ensure compliance with relevant laws and regulations when conducting share reductions and repurchases[96]. Legal and Compliance - The half-year financial report for the company has not been audited, indicating that the financial data may not have undergone external verification[112]. - There have been no bankruptcy reorganization matters reported during the reporting period, indicating financial stability[113]. - The company has not faced any significant litigation or arbitration matters during the reporting period, suggesting a low legal risk environment[114]. - The company is pursuing a claim against Henan Mengcheng Biopharmaceutical Co., Ltd. for 184,000 yuan, with the case still in execution[115]. Financial Strategy - The company has a plan to invest in various financial instruments, including corporate bonds and short-term financing bonds[75]. - The investment strategy focuses on high-credit, liquid financial assets, including government bonds and financial bonds[75]. - The company has engaged in entrusted financial management, with a total of CNY 22.8 million in financial products, including CNY 14.8 million in bank products and CNY 8 million in brokerage products[71]. - The company has a commitment to maintaining a balanced portfolio of financial assets to mitigate risks[77].

江苏久吾高科技股份有限公司 2018 年第一季度报告全文 江苏久吾高科技股份有限公司 2018 年第一季度报告 2018 年 04 月 1 江苏久吾高科技股份有限公司 2018 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2018 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入（元） | 46,015,898.53 | 42,343,169.12 | 8.67% | | 归属于上市公司股东的净利润（元） | 3,081,056.16 | 2,624, ...

Financial Performance - The company's operating revenue for 2017 was CNY 293,538,746.86, representing a 19.35% increase compared to CNY 245,949,178.12 in 2016[22]. - The net profit attributable to shareholders for 2017 was CNY 45,038,324.73, a 4.58% increase from CNY 43,064,659.92 in 2016[22]. - The net profit after deducting non-recurring gains and losses was CNY 37,541,840.06, which is a 12.39% increase from CNY 33,403,939.70 in 2016[22]. - The net cash flow from operating activities was negative CNY 76,369,589.16, a significant decrease of 589.64% compared to CNY 15,597,078.74 in 2016[22]. - The total assets at the end of 2017 were CNY 754,270,063.62, reflecting a 30.44% increase from CNY 578,264,603.54 at the end of 2016[22]. - The net assets attributable to shareholders increased by 48.07% to CNY 580,813,690.58 from CNY 392,253,349.45 in 2016[22]. - The basic earnings per share for 2017 were CNY 0.4683, down 16.42% from CNY 0.5603 in 2016[22]. - The weighted average return on equity for 2017 was 8.59%, a decrease of 2.95% from 11.54% in 2016[22]. - The quarterly operating revenue showed a steady increase, with Q4 reaching CNY 108,307,933.42[24]. - The net profit attributable to shareholders in Q4 was CNY 19,367,039.74, indicating strong performance in the last quarter[24]. Research and Development - The company focuses on the research and application of ceramic membrane materials and membrane separation technology, providing integrated solutions for process separation and special water treatment[32]. - The company has developed multiple core technologies in membrane separation, with many at a leading domestic or advanced international level[8]. - The company has established a complete research and development system for ceramic membrane materials and membrane separation technology, promoting continuous technological advancement[36]. - The company's R&D expenditure for 2017 was 17.07 million yuan, accounting for 5.82% of operating revenue, ensuring continuous improvement in technology and product development[45]. - The company is focusing on three main areas of technology research: foundational technology for ceramic membranes, membrane material preparation technology, and membrane application technology[37]. - The company has established several research platforms, including a national engineering research center for inorganic membranes, enhancing its R&D capabilities[45]. Market Position and Strategy - The company maintains a leading position in the domestic ceramic membrane industry, facing increased competition from both domestic and foreign companies[5]. - The company aims to enhance R&D investment and optimize management to maintain its competitive edge in a challenging market[5]. - The company plans to expand its application fields for membrane integration technology to smooth out industry fluctuations[6]. - The company is actively expanding its market presence in various downstream industries, including biomedicine, chemical and petrochemical, and special water treatment sectors[39]. - The company has identified new growth points in industrial wastewater treatment and resource utilization, particularly in areas such as titanium dioxide wastewater treatment and lithium extraction technology[40]. - The company aims to enhance its profitability through technological innovation and by offering comprehensive solutions and services to meet customer needs[33]. Financial Management - The company is focused on improving accounts receivable management to mitigate risks associated with increasing receivables due to macroeconomic conditions[7]. - The procurement strategy includes establishing alternative supplier plans to ensure the safety of raw material and component supplies[34]. - The company has seen a significant increase of 395.31% in other receivables, mainly due to an increase in bid guarantee deposits[42]. - The company's cash and cash equivalents decreased by 52.79% compared to the beginning of the period, primarily due to a reduction in net cash flow from operating activities[42]. - Accounts receivable increased by 30.43% compared to the beginning of the period, attributed to sales growth during the reporting period[42]. Corporate Governance and Compliance - The company has committed to improving corporate governance and risk management to protect investor interests[97]. - The governance structure complies with relevant laws and regulations, ensuring independent operation of the board of directors and supervisory board[193]. - The company held shareholder meetings in accordance with its articles of association, ensuring equal rights for all shareholders[193]. - There were no instances of the controlling shareholder interfering with the company's decision-making or operations during the reporting period[193]. - The company has committed to compensating investors for losses caused by false records or misleading statements in the prospectus[118]. Shareholder Information - The company reported a cash dividend of 1.30 RMB per 10 shares, totaling 102,624,000 shares[9]. - The cash dividend accounted for 29.62% of the net profit attributable to ordinary shareholders in 2017[105]. - The total share capital of Jiangsu Jiuwu High-Tech Co., Ltd. increased from 64.14 million shares to 102.624 million shares after the public offering and dividend distribution[155]. - The company distributed a cash dividend of 2.0 RMB per 10 shares and issued 6 bonus shares for every 10 shares held, resulting in a total share capital increase[156]. - The largest shareholder, Shanghai Dehui Group, holds 31.18% of the shares, amounting to 32 million shares[161]. Future Outlook - The company aims to become a leading enterprise in the ceramic membrane industry and a provider of integrated membrane technology solutions within a few years[94]. - The company plans to actively participate in the bidding for land use rights for project construction, with an area of 75,300.42 square meters[86]. - The company plans to enhance its business project operation capabilities and strengthen external collaborations in new fields such as lithium extraction, titanium dioxide wastewater treatment, and gas fermentation for ethanol production[95]. - The company has set a performance guidance of 1.5 billion RMB in revenue for the next fiscal year, aiming for a 25% growth[180]. - The management team emphasized a commitment to sustainability, aiming for a 30% reduction in carbon emissions by 2025[180].